Any arrival of U.S. Drug Enforcement Administration (DEA) agents triggers self-doubt and panic. What exactly should you do if DEA agents arrive at your practice?
|Heidi M. Dunniway, MD
The ISMA wants you to know how to respond and how to manage the various aspects of controlled substance prescribing. We are once again expanding physician education on this topic with our new Rx Pulse newsletter column.
As part of our Rx Pulse series, we will feature regular columns on controlled substance prescribing by physicians, ISMA staff and guest authors. Because DEA visits can be career-enders for physicians, we are kicking off our new series with an article by J. Richard Kiefer, JD, of Bingham Greenebaum Doll LLP. It explains what can happen when a physician is confronted by DEA agents.
Soon you’ll see an Rx Pulse article based on an interview with Josh Minkler, the new U.S. Attorney for the Southern District of Indiana. No stranger to drug abuse issues, Minkler was previously the chief of the office's Drug and Violent Crime Unit.
Physician advocacy and education have been ISMA’s mission since 1849. The ISMA has been on the front lines with the new opioid prescribing rules promulgated by the Medical Licensing Board (MLB) of Indiana.
Over the last few years, the ISMA has traveled the state to explain the rules at physician gatherings. We have offered webinars and live continuing medical education, like the one coming up Aug. 28. The ISMA has helped with each of the attorney general’s annual prescription drug abuse symposiums; the 2015 event will occur on Oct. 28-29 in Indianapolis.
The ISMA staff has attended hundreds of monthly meetings of the MLB and understands its expectations of physicians. We are now publishing the “lessons learned” from these MLB meetings, and we will continue to do so.
The Rx Pulse articles and other educational activities will help you with compliance and patient treatment. We’ll offer practical, everyday management tips for prescribing medication.
Your suggestions and comments are welcome; in fact, your feedback is essential. Please tell us what’s working for you or what we can do to help you more confidently manage your patients.
This Rx Pulse series is about patient safety at a time when more than 109 painkiller prescriptions are being written annually for every 100 Hoosier citizens, and Southern Indiana has an HIV epidemic from the illegal injection of Opana®.
Together, let’s protect our profession and our patients. Turn to Rx Pulse from the ISMA for education, tools and information to lead the way.
|Please note: Following this Aug. 10, 2015, issue, website access to our e-newsletter will become a members only feature on the ISMA website and will require logging in. As a member, you will continue to enjoy all the information as an exclusive value of your ISMA membership.